MT-TT

gene
On this page

Also known as trnT

Summary

MT-TT (mitochondrially encoded tRNA-Thr (ACN), HGNC:7499) is a mitochondrial tRNA gene on chromosome mitochondria.

Predicted to enable triplet codon-amino acid adaptor activity. Predicted to be involved in translation.

Source: NCBI Gene 4576 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (Mt_tRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:7499
Approved symbolMT-TT
Namemitochondrially encoded tRNA-Thr (ACN)
Locationmitochondria
Locus typeRNA, transfer
StatusApproved
AliasestrnT
Ensembl geneENSG00000210195
Ensembl biotypeMt_tRNA
OMIM590090
Entrez4576
RNAcentralURS00000FCDE9 — tRNA, 66 nt, 4 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 Mt_tRNA

ENST00000387460

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000387460 — 1 exons

ExonStartEnd
ENSE000015444751588815953

Expression profiles

Bgee: expression breadth ubiquitous, 118 present calls, max score 99.40.

FANTOM5 (CAGE): breadth broad, TPM avg 3.6321 / max 2116.6920, expressed in 609 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1950721.2047137
1950701.0074156
1950690.8276269
1950710.5924148

Top tissues by expression

118 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
skeletal muscle tissueUBERON:000113499.40gold quality
sural nerveUBERON:001548899.34gold quality
substantia nigraUBERON:000203899.00gold quality
apex of heartUBERON:000209898.81gold quality
caudate nucleusUBERON:000187398.71gold quality
putamenUBERON:000187498.70gold quality
olfactory segment of nasal mucosaUBERON:000538698.55gold quality
amygdalaUBERON:000187698.47gold quality
hypothalamusUBERON:000189898.44gold quality
Ammon’s hornUBERON:000195498.43gold quality
nucleus accumbensUBERON:000188298.29gold quality
duodenumUBERON:000211497.97gold quality
right frontal lobeUBERON:000281097.64gold quality
anterior cingulate cortexUBERON:000983597.58gold quality
mucosa of stomachUBERON:000119997.57gold quality
frontal cortexUBERON:000187097.52gold quality
C1 segment of cervical spinal cordUBERON:000646997.39gold quality
rectumUBERON:000105296.94gold quality
cerebral cortexUBERON:000095696.92gold quality
corpus callosumUBERON:000233696.38gold quality
prefrontal cortexUBERON:000045195.86gold quality
monocyteCL:000057695.66gold quality
leukocyteCL:000073895.63gold quality
right hemisphere of cerebellumUBERON:001489095.40gold quality
dorsolateral prefrontal cortexUBERON:000983495.34gold quality
brainUBERON:000095595.28gold quality
bone marrowUBERON:000237195.00gold quality
heart left ventricleUBERON:000208494.92gold quality
cerebellar hemisphereUBERON:000224594.81gold quality
vermiform appendixUBERON:000115494.30gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.46

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • the mitochondrial tRNA(Thr) A15951G mutation might be involved in the pathogenesis of Leber’s hereditary optic neuropathy in the two families. (PMID:21983721)
  • the tRNAThr 15927G > A mutation, identified in a large cohort of LHON subjects, decreased the activities of mitochondrial complexes I and III, markedly diminished mitochondrial ATP levels, and increased the production of reactive oxygen species in the mutant cells. (PMID:29225014)
  • A coronary artery disease-associated tRNAThr mutation altered mitochondrial function, apoptosis and angiogenesis. (PMID:30541130)
  • Maternally Inherited Diabetes Mellitus Associated with a Novel m.15897G>A Mutation in Mitochondrial tRNA(Thr) Gene. (PMID:32083134)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.